These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33717210)

  • 1. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review.
    Hanning N; Edwinson AL; Ceuleers H; Peters SA; De Man JG; Hassett LC; De Winter BY; Grover M
    Therap Adv Gastroenterol; 2021; 14():1756284821993586. PubMed ID: 33717210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Edogawa S; Edwinson AL; Peters SA; Chikkamenahalli LL; Sundt W; Graves S; Gurunathan SV; Breen-Lyles M; Johnson S; Dyer R; Graham R; Chen J; Kashyap P; Farrugia G; Grover M
    Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS.
    Wilcz-Villega E; McClean S; O'Sullivan M
    Neurogastroenterol Motil; 2014 Mar; 26(3):316-25. PubMed ID: 24286617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
    Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
    Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
    Wilcz-Villega EM; McClean S; O'Sullivan MA
    Am J Gastroenterol; 2013 Jul; 108(7):1140-51. PubMed ID: 23588236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.
    Peters SA; Edogawa S; Sundt WJ; Dyer RB; Dalenberg DA; Mazzone A; Singh RJ; Moses N; Smyrk TC; Weber C; Linden DR; MacNaughton WK; Turner JR; Camilleri M; Katzka DA; Farrugia G; Grover M
    Am J Gastroenterol; 2017 Jun; 112(6):913-923. PubMed ID: 28323272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome.
    Martínez C; González-Castro A; Vicario M; Santos J
    Gut Liver; 2012 Jul; 6(3):305-15. PubMed ID: 22844557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Lindsey PJ; Dekker J; Buurman WA; Masclee AA
    Aliment Pharmacol Ther; 2014 Aug; 40(4):392-402. PubMed ID: 24943480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
    Xu X; Liu L; Yao S; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review.
    Głąbska D; Kołota A; Lachowicz K; Skolmowska D; Stachoń M; Guzek D
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?
    Wang H; Gong J; Wang W; Long Y; Fu X; Fu Y; Qian W; Hou X
    PLoS One; 2014; 9(3):e90153. PubMed ID: 24595218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
    Long Y; Du L; Kim JJ; Chen B; Zhu Y; Zhang Y; Yao S; He H; Zheng X; Huang Z; Dai N
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13348. PubMed ID: 29644768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.